Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Small Cell 1

Interventions

Topotecan 4Cisplatin 4Etoposide 3belinostat 2Pemetrexed 2Paclitaxel 2Carboplatin 2vosaroxin 1vinflunine 1veliparib 1taxane 1sagopilone 1pembrolizumab 1lurtotecan 1liposomal doxorubicin 1belotecan 1Vinorelbine 1Tomography, X-Ray Computed 1Temozolomide 1Taxes 1Sorafenib 1RRx-001 1Quality of Life 1Positron-Emission Tomography 1Podophyllotoxin 1Platinum 1Patient Reported Outcome Measures 1PT-100 dipeptide 1Nortriptyline 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Small Cell × Nortriptyline × Clear all
NCT02881125 2019-12-17

Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma

University of Washington

Phase 1 Completed
2 enrolled

Carcinoma, Small Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡